ReachMD Faculty

Public Profile

Alan S. Brown, MD, FACC, FAHA, FNLA
Alan S. Brown, MD, FACC, FAHA, FNLA
  • Chief of Cardiology
  • Advocate Lutheran General Hospital
Program NameLast Air DateHosts/Guests
Exploring Emerging Non-Statin LDL Lowering Therapies03/26/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Maya S. Safarova, MD, PhD, FNLA
Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials01/30/2025
  • Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  • Alan S. Brown, MD, FACC, FAHA, FNLA
One Foundation's Approach to Preventing Sudden Cardiac Death in Young Athletes
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Joseph Marek, MD
Cardiac Rehabilitation: Key Considerations for Breast Cancer Survivors04/05/2023
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Maryam Lustberg, MD, MPH
Patching Up Cardiovascular Risk
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Sheng Xu, PhD
Exploring the Careers of Cardiologists: A Noninvasive Cardiologist's Journey & a First-Year Student…03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Heval M. Kelli, MD
  • Alan Amedi
Considering Cannabis & the Cardiovascular System: A Look at Patient Outcomes03/26/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Dustin Sulak, DO
ASCVD Risk & Women: Investigating Impact on Female Patients03/23/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Erin Michos
Coronary Heart Disease & Postmenopausal Women: Evaluating Risk Through Research03/26/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Yvonne Michael, ScD, SM
Exploring Strategies to Eliminate Disparities in Cardiovascular Care03/23/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
Detecting & Diagnosing Diabetes in Cardiology Patients03/26/2025
  • Matthew J. Sorrentino, MD, FACC, FASH
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Cardiology Among the Constellations: Exploring Microgravity & Space Flight03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Arun Sharma, PhD
Assessing Advancements in Preventative Cardiology03/22/2025
  • Matthew J. Sorrentino, MD, FACC, FASH
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Addressing Racial Disparities in Cardiovascular Care03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
At the Heart of Healthcare: Addressing the Future of Cardiology Care03/22/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Matthew Sorrentino, MD
Gazing into the Cardiology Crystal Ball: The Future of Preventive Care03/21/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Matthew Sorrentino, MD
Uncovering Evidence on Blood Pressure Improvements in Americans03/19/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Daniel T. Lackland DrPH
How Does COVID-19 Affect the Heart?03/22/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Jennifer N. Avari Silva, MD
Meet Alan Brown, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Treating Erectile Dysfunction: Key Cardiovascular Considerations03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Pharmacometabolomics to Predict Statin Response: Ready for Prime Time?03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines03/14/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
PCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease03/22/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Canadian Perspectives on Managing Lipid Disorders in Children03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Lipid-Lowering Drug Interactions in Cardiovascular Agents03/23/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Selecting the Right Contraception for the Dyslipidemic Woman03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Robert Wild, MD, MPH, D.Phil.
Lipidologists Confronting the Obesity Epidemic: Perspectives from NLA President Joyce Ross03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Joyce Ross
Big Data in Lipids: Refining Cardiovascular Risk Profiles Nationwide 03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies03/22/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA
What's the Deal with Saturated Fat and Cardiovascular Disease Risk?03/23/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guidelines03/26/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
The Lipidology Essentials: Making of a Specialty's Annual Summary03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Harold Bays, MD, FNLA
Clinical Decisions on Cardiovascular Disease: Are Risks or Causes Your Guide?03/26/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Allan Sniderman, MD
Pathways Toward Better Lipid Medication Adherence03/22/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Special Populations in Patient-Centered Management of Dyslipidemia03/21/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Dyslipidemia in The Elderly: How Old is "Too Old" to Treat? 03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA
Guidelines for Diagnosis and Management of Dyslipidemia in Patients with HIV03/17/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Updated NLA Recommendations for African American Patients03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
Dyslipidemia in Children and Adolescents03/22/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Million Hearts Initiative with Dr. Janet Wright, Executive Director03/20/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Janet Wright, MD
Dyslipidemia During Pregnancy: The Risks for Two Patients03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Statin Intolerance: Keys to Patient Counseling and Guidance03/22/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Roles of Non-HDL Cholesterol in Risk Assessment and Treatment03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Keys to the Latest NLA Recommendations for Dyslipidemia Treatments03/18/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Management of the Patient With Triglycerides 200-499 mg/dl.03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Carl Orringer, MD, FACC, FNLA
What is the Safety of Statins in Patients with Diabetes?03/23/2025
  • Kevin C. Maki, PhD, FNLA, CLS
  • Alan S. Brown, MD, FACC, FAHA, FNLA
A Synopsis of the ACC/AHA Risk Assessment and Cholesterol Guidelines03/22/2025
  • Anne Goldberg, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia03/25/2025
  • Kevin C. Maki, PhD, FNLA, CLS
  • Carl Orringer, MD, FACC, FNLA
  • Harold Bays, MD, FNLA
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Matthew Ito, PharmD, FNLA
New Insights on Statin Therapy for Older Patients03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
HPS-2 THRIVE Data and Results03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Health Information Technology's Impact on Adherence to Lipid Therapy03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Cardiometabolic Consequences of Sitting Time03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Generics and Manufacturing: What Prescribers Need to Know03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Genetic Testing for Familial Hypercholesterolemia03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Research Updates in Familial Hypercholesterolemia03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Research Updates on Postprandial Dyslipidemia Treatment02/25/2016
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Lipid Biomarker Updates: When to Move Beyond the Standard Profile03/23/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
What is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Patie…03/26/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Adiposity, Obesity, and Dyslipidemia03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Researching Oxidized High-Density Lipoprotein in Obese Adolescents03/17/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Underrecognition of Diabetes in Cardiology Practice03/23/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
An Avocado a Day: Does It Keep Heart Disease Away?03/08/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
The Impact of Inflammation on HDL Activity03/23/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Changing Nutritional Needs Throughout the Lifetime03/23/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Rebecca S. Reeves, DrPH, RD, FADA
Managing CVD in Women During Childbearing Years09/03/2015
  • Robert Wild, MD, MPH, D.Phil.
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Obesity, Diabetes and the Metabolic Syndrome03/06/2015
  • Kevin C. Maki, PhD, FNLA, CLS
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Broken Hearts or Broken Bones?03/19/2025
  • Janet Maxson, PhD, FNP
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Non-pharmacologic Approaches to the Metabolic Syndrome and Diabetes09/25/2015
  • Neil Stone, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Evolving Treatments: A Review of What’s in the Pipeline06/14/2013
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Harold Bays, MD, FNLA
Fish Oils: Are They Still Cardioprotective?03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • William S. Harris, PhD
Treatment Options for Polycystic Ovarian Syndrome (PCOS)04/20/2018
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Debra Friedrich, DNP, ARNP, FNP-C, CLS
Controversy Surrounding the NHLBI Pediatric Guidelines03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Samuel Gidding, MD
Statin Safety Considerations03/24/2025
  • Dean A. Bramlet, MD, FACC, FACP
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Emerging LDL Therapies03/20/2025
  • Peter Toth, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Emerging HDL Therapies: What’s Next on the Clinical Research Horizon03/25/2025
  • Benjamin J. Ansell, MD, FACC, FACP, FNLA
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Understanding Why Patients Discontinue Statin Therapy03/19/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Jerome D. Cohen, MD
Statin Therapy and Diabetes Incidence03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Spencer Kroll
Lipids and Hormone Therapy03/24/2025
  • Janet Maxson, PhD, FNP
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Diet Controversies in Lipid Lowering & Cardiovascular Disease Prevention03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Mary Felando, MS, RD
Biomarkers and Lipidology03/24/2025
  • Michael H. Davidson, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Diagnosis, Prevalence, and Screening of Familial Hypercholesterolemia03/24/2025
  • Paul N. Hopkins MD MSPH
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Fat, Exercise and Cholesterol03/22/2025
  • Harold Bays, MD, FNLA
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Managing Lipids in the Chronic Kidney Disease Patient03/22/2025
  • George L. Bakris, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Coronary CT Angiography03/26/2025
  • Seth Baum, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Genetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease03/24/2025
  • Christie Ballantyne, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Management Issues in Familial Hypercholesterolemia03/23/2025
  • Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Familial Hypercholesterolemia: Risk Stratifications in Practice03/19/2025
  • Jennifer Robinson, MD, MPH
  • Alan S. Brown, MD, FACC, FAHA, FNLA
From Experts to Analytics: What Does Evidence-Based Medicine Mean?01/25/2013
  • Robert Wild, MD, MPH, D.Phil.
  • Alan S. Brown, MD, FACC, FAHA, FNLA
CIMT Appropriate Use Guidelines03/08/2025
  • Edward Gill, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Personalizing Dietary Approaches for Cardiovascular Health03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Penny Kris-Etherton
LDL Apheresis03/25/2025
  • James Falko, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Imaging Guidelines for Screening CV Risk03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Allen Taylor, MD
Fundamentals of Fatty Acids03/25/2025
  • Kevin C. Maki, PhD, FNLA, CLS
  • Alan S. Brown, MD, FACC, FAHA, FNLA
It's Relative: Screening and Treating Familial Hypercholesterolemia03/26/2025
  • Anne Goldberg, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Caring for Un- and Under-Insured Patients on Lipid Therapy03/20/2025
  • Carl Orringer, MD, FACC, FNLA
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Current Inquiries in Lipidology: The NLA's Role in the Field06/03/2011
  • Michael H. Davidson, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Predictive Value of Lipid Biomarkers and Inflammatory Markers05/06/2011
  • Michael H. Davidson, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
The Importance of Omega-3 Fatty Acids03/24/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • William S. Harris, PhD
Metabolic Syndrome in African Americans: Risk Adjustments & Treatments03/25/2025
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
Atherosclerosis and Cardiovascular Risk Factors in Children03/26/2025
  • Samuel Gidding, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Cardiometabolic Risk Reduction in Native Americans03/20/2025
  • Ralph LaForge
  • Alan S. Brown, MD, FACC, FAHA, FNLA
The Process of Developing Clinical Guidelines10/08/2010
  • Luther Clark, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Updates on the ACCORD Trial From the 2010 National Lipid Association Meeting10/01/2010
  • John Robin Crouse, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Lipid Management and Systemic Approaches to Patient Care09/10/2010
  • Ann Liebeskind, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Heart Disease in the United States: Past, Present, and Future Trends10/15/2010
  • Thomas Allison, PhD, MPH
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Behavioral Strategies for Managing Weight03/24/2025
  • John Foreyt, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Exercise as Medicine03/26/2025
  • Carol Garber, PhD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • James Whitehead
Using HDL in the Clinical Setting03/24/2025
  • W. Virgil Brown, MD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Particle Number Testing in the Prevention of Atherosclerosis03/24/2025
  • Tara Dall
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Strategies to Help Reduce Diseases Associated with Lifestyle03/25/2025
  • Penny Kris-Etherton, PhD, RD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Reevaluating Heart Protective vs Destructive Dietary Fats03/18/2025
  • Lawrence Rudel, PhD
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Dietary Fats and Cardiovascular Disease03/21/2025
  • Wahida Karmally, PH, RD, CDE, CLS
  • Alan S. Brown, MD, FACC, FAHA, FNLA
Looking Beyond LDL to Reduce Cardiovascular Events11/02/2008
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Larry Kaskel, MD
The Latest Targets of Lipid Therapy09/07/2008
  • Alan S. Brown, MD, FACC, FAHA, FNLA
  • Larry Kaskel, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
PrevNext